Death triggers FDA hold on Foghorn blood cancer clinical trial, shrouding timing of data drop
Death triggers FDA hold on Foghorn blood cancer clinical trial, [...]
Bayer pulls plug on $670M CAR-T cell therapy pact with Atara in wake of patient death
Bayer pulls plug on $670M CAR-T cell therapy pact with [...]
Chutes & Ladders—Aquestive CEO heads for the exits while seizure med remains in regulatory limbo
Chutes & Ladders—Aquestive CEO heads for the exits while seizure [...]
Inceptor Bio to use $37M series A to nudge CAR-T toward clinic, establish manufacturing base
Inceptor Bio to use $37M series A to nudge CAR-T [...]
Amgen celebrates 25 years of deCODE Genetics as partnership evolves from discovery to development
Amgen celebrates 25 years of deCODE Genetics as partnership evolves [...]
Enanta sinks to multiyear low as phase 2b RSV trial flames out
Enanta sinks to multiyear low as phase 2b RSV trial [...]
Nanobiotix scales down R&D plan, freezes hiring to close gap between cash runway and phase 3 data
Nanobiotix scales down R&D plan, freezes hiring to close gap [...]
Merck to pay up to $1.4B in cancer deal with Kelun, but details are scarce
Merck to pay up to $1.4B in cancer deal with [...]
Applied Molecular Transport’s co-founder exits along with 40% of staff as early pipeline activity paused
Applied Molecular Transport’s co-founder exits along with 40% of staff [...]
‘We just don’t have the studies’: New report details critical diversity shortcomings in US clinical research
‘We just don’t have the studies’: New report details critical [...]